Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Makhoul

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Human Vaccines & Immunotherapeutics|December 9, 2014
Moving a Carbohydrate Mimetic Peptide into the clinicIssam Makhoul, Laura Hutchins, Peter D Emanuel, et al.
Cancer Biology & Therapy|May 18, 2017
Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattackFade Mahmoud, Bradley Shields, Issam Makhoul, et al.
International Journal of Molecular Sciences|September 14, 2024
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast CancerValentina K Todorova, Gohar Azhar, Annjanette Stone, et al.
American Journal of Cancer Research|October 12, 2020
Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patientsValentina K Todorova, Ping-Ching Hsu, Jeanne Y Wei, et al.
American Journal of Clinical Oncology|April 9, 2013
Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancerIssam Makhoul, Vicki Suzanne Klimberg, Soheila Korourian, et al.
Translational Oncology|January 10, 2020
Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer ModelValentina K Todorova, Eric R Siegel, Yihong Kaufmann, et al.
JCO Oncology Practice|November 14, 2022
Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare DataAlan P Baltz, Eric R Siegel, Arif H Kamal, et al.
Cancers|November 27, 2021
Genomic and Transcriptomic Profiling of Brain MetastasesChristopher P Wardell, Emilie Darrigues, Annick De Loose, et al.
Plos One|April 17, 2020
Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancerPing-Ching Hsu, Susan A Kadlubar, Eric R Siegel, et al.
Breast Cancer : Basic and Clinical Research|June 9, 2018
Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port CathetersDanielle Tippit, Eric Siegel, Daniella Ochoa, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Human Vaccines & Immunotherapeutics|December 9, 2014
Moving a Carbohydrate Mimetic Peptide into the clinicIssam Makhoul, Laura Hutchins, Peter D Emanuel, et al.
Cancer Biology & Therapy|May 18, 2017
Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattackFade Mahmoud, Bradley Shields, Issam Makhoul, et al.
International Journal of Molecular Sciences|September 14, 2024
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast CancerValentina K Todorova, Gohar Azhar, Annjanette Stone, et al.
American Journal of Cancer Research|October 12, 2020
Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patientsValentina K Todorova, Ping-Ching Hsu, Jeanne Y Wei, et al.
American Journal of Clinical Oncology|April 9, 2013
Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancerIssam Makhoul, Vicki Suzanne Klimberg, Soheila Korourian, et al.
Translational Oncology|January 10, 2020
Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer ModelValentina K Todorova, Eric R Siegel, Yihong Kaufmann, et al.
JCO Oncology Practice|November 14, 2022
Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare DataAlan P Baltz, Eric R Siegel, Arif H Kamal, et al.
Cancers|November 27, 2021
Genomic and Transcriptomic Profiling of Brain MetastasesChristopher P Wardell, Emilie Darrigues, Annick De Loose, et al.
Plos One|April 17, 2020
Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancerPing-Ching Hsu, Susan A Kadlubar, Eric R Siegel, et al.
Breast Cancer : Basic and Clinical Research|June 9, 2018
Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port CathetersDanielle Tippit, Eric Siegel, Daniella Ochoa, et al.
Pageof 9